The wrist is the most commonly involved region of the upper extremity in rheumatoid arthritis (RA), and about 75% of RA patients showed wrist symptoms. 1, 2 Because the wrist joint becomes involved early during the disease course and its involvement rapidly progresses, and because the disabilities associated with progressive RA are significant, early and adequate treatment must be introduced to prevent disease progression. RA of the wrist can be treated conservatively or surgically, such as synovectomy, wrist arthrodesis and arthroplasty. [3] [4] [5] [6] [7] Conventional open surgical synovectomy is used to reduce symptoms and increases joint function in patients with early stage RA. In the early 1980s, arthroscopic synovectomy was first introduced to treat knee joints, and in the 1990s the technique and the instrumentation (particularly of small joint arthroscope and motorized instruments) were further developed and resulted in an increase in the use of wrist arthroscopy. 8 Arthroscopic synovectomy produced results similar to those of conventional surgery and satisfactory results in RA patients with refractory wrist swelling. 4, [9] [10] [11] As compared with conventional surgical synovectomy, the arthroscopic technique has several advantages: less postoperative morbidity, minimal surgical trauma, short hospital stay and early rehabilitation. Arthroscopic synovectomy is commonly recommended in early stage RA, but it has not been recommended when a substantial degree of wrist joint destruction is present. In patients with advanced wrist damage, arthrodesis or wrist arthroplasty has been usually recommended. Recently, promising results for arthroscopic synovectomy have been reported in advanced staged RA of the wrist. 4 ,10 Thus, we undertook to review published results of arthroscopic synovectomy for early stage and advanced stage RA of the wrist. 12 
ANATOMY AND PATHOMECHANISM
The wrist provides stability and function to the hand. It is a complex structure comprised of three major synovial compartments: the radiocarpal, midcarpal and distal radioulnar, and surrounding stabilizing structures, such as the radiocarpal ligament, intercarpal ligament, triangular fibrocartilage complex (TFCC) and surrounding tendons. The distal radius and ulna articulate with each other at the distal radioulnar joint, and the distal radius articulates with the carpus (carpal bones) at the radiocarpal joint, which is EVALUATION During early stage RA, wrist pain, tenderness and bulging of the dorsal wrist (which indicates synovitis) are developed and are reversible, whereas during advanced stage, prominence of ulnar head by ulnar dorsal subluxation of carpus and widening of the anterior-posterior dimension of the wrist by volar subluxation of carpus are likely. In addition, range of motion (flexion, extension, supination, pronation), grip strength and function may be affected, although standardized functional assessment methods did not seem to be. We routinely assess patients by allocating modified Mayo wrist scores (table 1) . 18 Standard radiographs play an important role during assessments of RA progression, and early diagnosis is required for proper management to prevent irreversible joint destruction, or at least retard disease progression. In recent study, magnetic resonance imaging (MRI) and ultrasound have enhanced usefulness. The study showed that the MRI revealed typical bony changes in early RA when conventional radiographs were normal. In addition, satisfactory results have been reported on the sensitivity and specificity of ultrasonography, especially for contrastenhanced ultrasonography for assessments of joint vascularity, a parameter of disease activity. [19] [20] [21] [22] [23] [24] [25] [26] 
CLASSIFICATION
In determining disease stage, assessments of erosion, joint space narrowing and cartilage loss by standard x-ray are considered an objective parameter. Many methods and essentially an articulation between the radius proximally and the scaphoid and lunate distally. The ulna is separated from the proximal row of carpal bones by the TFCC, a fibrocartilaginous disc that stretches from the medial aspect of the distal radius to the ulnar styloid. 2, 13, 14 Synovial hyperplasia with extensive infiltration by inflammatory cells is a characteristic of RA. Various studies have suggested that growth factors and cytokines like tumor necrosis factor (TNF) and interleukin (IL)-1 play important roles during the initiation and progression of RA. [15] [16] [17] Moreover, because RA is essentially a synovial disease, each of the three separate compartments may become involved at disease onset. The tendon and ligament also become lax. In addition, when chronic rheumatoid joint inflammation persists, cartilage and periarticular bone are destroyed to variable extents due to the actions of inflammatory cytokines, and the resulting wrist imbalance may cause wrist deformity. Radiologically, periarticular osteoporosis, erosion, joint space narrowing, dislocation or ankylosis are typical findings in chronic RA. Radiocarpal involvement leads to rotatory instability of the scaphoid with resultant wrist collapse, loss of carpal height, ulnar and volar (palmar) translocation of the carpus on the radius, imbalance of the extensor tendon, a radial shift of metacarpals and ulnar deviation of fingers at metacarpophalangeal joints. The end stage rheumatoid wrist is dislocated volarly with complete destruction of the carpus and with dissociation of the distal radioular joint. 13 Kim 
TREATMENT
The treatment of RA places a focus on pain relief and functional recovery, and on the resultant ability to work and improved life expectancy. Current therapeutic modalities cannot completely cure RA but do reduce discomfort and retard disease progression. The treatment is more efficient during early stage disease.
Nonoperative Treatment
A detailed understanding of the molecular immunology of RA has led to a transition from conventional treatments, such as nonsteroidal anti-inflammatory drugs (NSAID), glucocorticoids, disease-modifying anti-rheumatic drugs (DMARD) to aggressive immune suppression based on biological agents (TNF and IL-1 antagonists) that control TNF-α and IL-1, and thus, the inflammatory process. 30 A brace is often used to maintain a stable joint position and in conjunction with modifying patient activity. 14, 31, 32 The introduction of biological agents has resulted in dramatic changes in the therapeutic approach and treatment paradigms for patients with RA. However, the cost should be considered because these agents are expensive. The National Institute for Health and Clinical Excellence (NICE) 2002 guidance for the use of TNF inhibitors recommended that etanercept and infliximab be used in patients with clinically active disease that has not responded adequately to at least two DMARDs, including methotrexate (unless contraindicated). There have been variable implementations of the guidelines with limited access to these agents in some areas. In the United States, the average wholesale price in 2006 for 1 year of therapy using the standard RA dose of either etanercept or adalimumab was approximately $16,000. 33 Yen 34 recommended that a sufficient trial of conventional DMARDs should be performed before the use of expensive biological treatments in cases of early RA in developing countries. Some patients with chronic RA refractory to the above-described medical treatments also require local or surgical treatment. Medical synovectomy, which is an injection of chemicals or radioisotopes into the joints, has been used in clinical practice as a local treatment alternative to surgical synovectomy.
CHEMICAL SYNOVECTOMY
The theoretical and practical advantages include minimal burden to the patient, simplicity of the technique with fewer associated risks, ability to reach areas inaccessible to surgery, minimal or no hospitalization, simple rehabilitation and low cost. Chemical synovectomy has historically been used with the help of various products, such as osmic acid, alkylating agents such as nitrogen mustard and thio-tepa, methotrexate and antibiotics. 35 Eventually, nitrogen mustard, thio-tepa, methotrexate and antibiotics fell into disuse because of their adverse effects or lack of efficacy on the cartilage, even though osmic acid is still used occasionally in some countries. [36] [37] [38] [39] RADIATION SYNOVECTOMY Synovectomy by radioisotopes was first attempted in the 1950s. Radiation synovectomy is a regularly practiced nuclear medicine therapy in patients suffering from pain, recurrent joint effusion and restricted movement due to inflammatory and degenerative joint disease. 40 The rationale of this technique is as follows: the radiopharmaceutical agent should have specific properties. The radiation energy should be sufficiently high to penetrate and ablate the synovial tissue but not so great as to damage the underlying articular cartilage or overlying skin. The radionuclide should be attached to particles that are sufficiently small to be phagocytosed but not so small that they might leak out of the joint before phagocytosis occurs. Furthermore, the particle should be biodegradable otherwise granulomatous tissue might form. Various β-emitting radioisotopes, e.g. Yttrium-90, Rhenium-186, erbium-169, are available. 36, 41 Following an intraarticular injection of a β-emitting radioisotope with a very short range, local irradiation resulted in sclerosis and finally fibrosis of the synovial membrane, achieving a significant reduction in pain and joint effusion. Radiation synovectomy is suitable for patients who suffer from clinical symptoms under standardized anti-rheumatoid drug therapy and in whom a pretherapeutic three-phase bone scan shows clear signs of hyperperfusion in their painful joints that is indicative of synovitis. The best results are produced in patients in the early stage of true RA. [42] [43] [44] In RA wrist treated with radiation synovectomy using Rhenium-186, Kampen et al 44 Meanwhile, several studies reporting the results of arthroscopic synovectomy showed clinical improvement in almost all patients, even though the results of radiation synovectomy in the wrist joint could not be compared with surgical synovectomy because the tools for measuring the clinical and radiological outcomes in each study were not standardized. Radiation synovectomy has several advantages. It is free of surgical risk, includes the need for little or no hospitalization, does not involve physical therapy, has lower costs than the alternatives and allows repeated injection. Siegel et al 45 reported that it also showed results equivalent to those of surgery. Therefore, radiation synovectomy appears to be an effective alternative to surgical synovectomy, and is also the procedure of choice for patients for whom surgery is contraindicated.
Surgical Treatment
In cases refractory to conservative treatment, surgical procedures are recommended. The generally accepted indications are when symptoms are not controlled despite conservative treatment for at least 6 to 9 months and when carpal deformity is found to progress. Various surgical procedures have been introduced with successful results, i.e., open synovectomy, arthroscopic synovectomy, wrist arthrodesis and total wrist arthroplasty. Choice of surgical procedure is based on radiologically-determined disease stage and also on the surgeon's preference. Open or arthroscopic synovectomy can provide pain relief with preserved or improved mobility in early stages of RA with joint space preservation, although synovectomy has been a controversial procedure. 4, 9, 10 For patients with advanced radiographic changes, such as marked joint cartilage destruction, wrist arthrodesis or arthroplasty are usually recommended. Combined radiation and arthroscopic synovectomy also shows promise in treating RA. Surgical synovectomy was first described more than 100 years ago and is a well accepted treatment method for RA joints. The theoretical rationale of synovectomy is to reduce or eliminate aggressive inflammatory cell mass, thereby improving function and reducing secondary pain.
OPEN SYNOVECTOMY An open wrist synovectomy is standard and allows an inspection of all compartments as well as the extensor tendons. There is some controversy regarding the effectiveness of synovectomy. Several authors have reported that wrist synovectomy provides consistent and dramatic pain relief and maintains grip strength with a lower probability of tendon rupture, even if halting of the disease process is not demonstrated, but causes varying losses of wrist motion in the long term. 13, 40, [46] [47] [48] [49] [50] However, some investigators claim that pain relief occurs at the expense of loss of joint motion and also the effect is ultimately transitory, with recurrence depending on the activity of the underlying cause of the arthritis. 13 The wrist synovectomy is contraindicated in patients with rapidly progressed disease with joint destruction.
ARTHROSCOPIC SYNOVECTOMY
Although, an open wrist synovectomy is standard and allows an inspection of all compartments, as well as the extensor tendons, arthroscopic synovectomy has been used successfully in select patients. Arthroscopic synovectomy offers advantages over open tenosynovectomy. Arthroscopic synovectomy is a surgical procedure with minimal morbidity, which does not require open arthrotomy, and leaves less joint capsule and ligament damage, thus allowing immediate mobilization and reducing hospital stays. 4, 11, 51 In addition, as compared with open arthrotomy, the arthroscopic technique offers superior views, easier access to radiocarpal and midcarpal compartments and facilitates the effective removal of pathologic synovium. 52 Moreover, subsequent reductions in postoperative morbidity have made arthroscopic synovectomy widely applicable.
Surgical Technique
A standard wrist arthroscopy technique 53, 54 is performed with a patient placed in the supine position and the shoulder abducted at 90 degrees on an arm board. A pneumatic tourniquet is applied to the upper arm, and the forearm is suspended in a wrist traction device. The second and third fingers are then placed under 7 to 10 pounds of traction and a 1.9 mm diameter, 30 degree-arthroscope (Dyonics, Andover, MA) is initially placed into a 3 to 4 portal and then into a 6-R portal for diagnostic wrist arthroscopy. Synovectomy of all visibly inflamed synovial tissues is performed using a 1.9 mm full-radius motorized suction shaving device, and debridement of pannus on the articular surface is then performed. To examine the midcarpal joint, another accessory portal is established, including the midcarpal radial and midcarpal ulnar portals. Debridement of the inflammatory synovial joints is done.
Literature Review
Arthroscopic synovectomy is a well-accepted method in early stage RA, but its use is controversial in advanced RA of the wrist. A search was made using the MESH terms, arthroscopic synovectomy, wrist and rheumatoid arthritis through the Medline and Embase databases and the Cochrane library for systematic reviews published from January 1977 to May 2007. The literature showed that arthroscopic synovectomies of rheumatoid wrists produced promising results. 4, 10 As compared with open synovectomy, the complications and morbidities associated with arthroscopic synovectomy are less. Adolfsson and Nylander 9 reported the results of arthroscopic synovectomy in 18 wrists of 16 patients. Synovectomy was found to provide good pain relief in all cases, a motion increase from 69.5 to 90 degrees on average range of extension and flexion, and overall increase of grip strength of 87% in comparison with preoperative status at 6-month follow-ups. In another study by Adolfsson and Frisen 4 with mean follow-up of 3.8 years, arthroscopic synovectomy was performed on 24 wrists with early stage RA. Pain was improved in 19 wrists, unchanged in 2 and worsened in 3. Range of motion increased from 74 to 90 degrees in the average flexion-extension arc and increased from 138 to 152 degrees in supination-pronation arc. In a study by Park et al 10 with a mean follow-up of 29 months, arthroscopic synovectomy was performed on 18 patients (19 wrists); preoperatively 13 wrists were radiologically Larsen stage I, 4 were Larsen stage II, 1 was Larsen stage III, and 1 was Larsen stage IV. Mean pain scores improved from 8 preoperatively to 4.5 postoperatively on the visual analogue scale (VAS; 10 points for worst possible pain and 0 points for no pain) and mean flexion-extension arc increased from 81 to 92 degrees. Patient satisfaction was high. The authors also recommend arthroscopic wrist synovectomy in patients with advanced radiographic changes and described promising results. However, their studies mainly focused on the outcome of arthroscopic synovectomy in patients with early-stage RA. 4, 9, 10 Moreover, results of arthroscopic synovectomy for patients with Larsen stage III are not well described. In Adolfsson's review 46 only a small number of patients with radiographic changes corresponding to grades III and IV of the Larsen-Dale-Eek index benefit from surgery and arthroscopic synovectomy was recommended on patients with stage II or less. However, advanced RA wrist results were not evaluated in detail. Although our previous study 12 was small in number, i.e., it included 11 patients with Larsen stage III RA with medium cartilage destruction (designated group A), this study revealed a promising clinical result for patients with Larsen stage III RA and medium cartilage destruction and joint space narrowing of 25% to 50%. Referring to our previous study 12 in early stage RA (group B), pain was improved from 8 preoperatively to 4.5 postoperatively using the VAS scale. Assessments of individual components of modified Mayo wrist scores showed that pain scores increased from a mean of 6.25 preoperatively to 20.0 after an average follow-up of 69.5 months (range 33 to 118 months). Range of motion increased from 106 to 108 degrees in the average flexion-extension arc. However, no significant differences were observed between preoperative and postoperative score with respect to range of motion, grip strength and return to work status. Total modified Mayo wrist scores increased (P = 0.02) from an average of 67.5 points preoperatively to an average of 83.75 points at final follow-up.
Patients with Larsen stage III RA (group A) also showed improvements in pain score, which decreased from 8.4 preoperatively to 5.1 postoperatively in the VAS scale. The modified Mayo wrist score for pain increased from a mean of 3.63 preoperatively to 18.18 at final follow-up, return to work status score increased from 6.81 preoperatively to 16.36 at final follow-up and range of motion increased from 51 to 62 degrees. No significant differences in ROM or grip strength scores were observed. Total modified Mayo wrist scores increased from an average of 26.36 points preoperatively to an average of 56.36 points at final follow-up. On comparing groups A and B, group A was found to have a lower score for each preoperative component of the modified Mayo wrist scoring system than group B, with the exception of pain score. Increase was observed between preoperative and final follow-up scores in terms of return to work status and total modified Mayo wrist scores. Group A showed larger differences in this context than group B (table 3). Our data suggest that arthroscopic synovectomy is a useful treatment for modest and moderate RA and that it is particularly effective at reducing pain and improving function, and thus allowing patients to have early return to work. However, this does not mean that it prevents radiographic disease progression. In Adolfsson and Frisen's study 4 , which compared preoperative and postoperative x-rays using the Larsen staging system, 10 of 13 wrists with grade II or III disease at the time of surgery revealed arthritic degenerative change progression by at least one grade, and this progression was significantly less common for preoperative grades 0 and I. In Park et al's study, 10 4 of 19 wrists showed progression after synovectomy. These changes occurred slowly as reflected by mean modified Larsen scores (9.8 preoperatively and 13.9 at final follow-up). In our study, 12 4, 9 reported no complications associated with surgery. In our study, 12 one patient showed immediate numbness of the superficial radial nerve territory, which might have been injured at the 3 to 4 portal position but disappeared 1 month after surgery. More recently, injury to the posterior interosseous nerve has been reported during arthroscopy. 55 In order to avoid many potential complications, a blunt dissection to the level of the wrist capsule with a hemostat should be made to limit injury to the sensory nerves and extensor tendons. The instruments should not be forced into a joint because this increases the potential for iatrogenic chondral lesions. 56 COMBINED RADIATION AND ARTHROSCOPIC SYNOVECTOMY To our knowledge, there are no published articles on these combined procedures. Due to the anatomical characteristics of the wrist consisting of multiple articulations, a total synovectomy appears to be difficult to accomplish even though arthroscopy of the wrist has been advanced along with the development of instruments. Considering the abovedescribed rationale and the clinical result of both techniques, we believe that combined radiation and arthroscopic synovectomy can be performed to acquire a more complete synovectomy than arthroscopic synovectomy alone. However, an investigation into the clinical results and cost effectiveness of the combined procedure will be needed in the future.
WRIST ARTHRODESIS AND TOTAL WRIST ARTHROPLASTY Wrist arthrodesis is the most commonly performed bony procedure in RA. Wrist fusion is indicated for advanced RA with severe radiocarpal instability, midcarpal involvement and the absence of wrist motors as a salvage procedure. 2 However, a lack of patient satisfaction with fusion has led to continued efforts to develop a total wrist implant. The indication for total wrist arthroplasty is painful, pancarpal advanced RA in a patient willing to accept a low demand lifestyle, but who desires the ability to perform activities.
SUMMARY
Various treatment methods can be employed to treat RA wrists based on radiological and clinical situations. Arthroscopic synovectomy is recommended for pain relief and functional recovery in early stage RA, and also helpful in advanced staged RA with Larsen stage III. However, we cannot suggest that arthroscopic synovectomy is an effective method of treatment for all patients with advanced radiographic changes. Nevertheless, arthroscopic synovectomy may delay the need for complex surgery, such as wrist arthrodesis or total wrist arthroplasty, and also can be considered before performing arthrodesis or arthroplasty. Although arthroscopic synovectomy of the wrist cannot improve grip strength or range of motion, it can reduce wrist pain and improve function, and thus facilitate early return to work.
